Evaluation of hepatic, renal and cardiac diagnostic markers in patients severe with COVID- 19
Abstract: SARS-CoV-2 that causes Coronavirus disease 2019 (COVID-19) was first known in Wuhan, China, in December 2019. The aim of this study was to evaluate the level of common hepatic, renal and cardiac diagnostic markers in hospital in patients with severe COVID 19. In this study, 259 patients wi...
Guardado en:
Autor principal: | Esmat Radmanesh |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Tehran University of Medical Sciences
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/bb7b1b124c924088a503760f974053d6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Dysgeusia and COVID-19: the Importance of the Dentist in the Diagnostic
por: Cral,Wilson Gustavo, et al.
Publicado: (2021) -
Laboratory diagnostic value of neopterin measurements in patients with COVID-19 infection
por: Fuchs Dietmar, et al.
Publicado: (2021) -
An evaluation of a diagnostic test to identify the sex of farmed rainbow trout, using sex-specific molecular markers
por: López,María E, et al.
Publicado: (2012) -
Rapid, Cheap, and Effective COVID-19 Diagnostics for Africa
por: Lukman Yusuf, et al.
Publicado: (2021) -
Diagnostic Value of Imaging Combined With Tumor Markers in Early Detection of Lung Cancer
por: Su-Ju Wei, et al.
Publicado: (2021)